Chemicals and Drugs [D] » Complex Mixtures [D20] » Biological Products » Vaccines » Viral Vaccines » Papillomavirus Vaccines » Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Chemicals and Drugs [D] » Complex Mixtures [D20] » Biological Products » Vaccines » Vaccines, Combined » Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Description
A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from human papillomaviruses of these subtypes. MeSH
Hierarchy View
Phase 4 Indicated Drugs (1)
Other Experimental Indicated Drugs (2)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
